Nutrition and cancer: Salvestrol case studies

Journal of Orthomolecular Medicine

Volumn 22, Issue 4, 2007, Pages 177-182

  Schaefer, Brian A ^a   Tan, Hoon L ^b   Burke, M Danny ^c   Potter, Gerard A ^d  

^a Clinical Intelligence Corp   (Canada)

^b Nature's Defence Investments   (United Kingdom)

^c Nature's Defence Investments ^*

^d DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

CYP1B1; Cytochrome P450; Natural anticancer prodrug; Salvestrols

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; CYTOCHROME P450; CYTOCHROME P450 1B1; DOCETAXEL; DOXORUBICIN; LEUPRORELIN; MAGNESIUM; NICOTINIC ACID; SALVESTROL; UNCLASSIFIED DRUG;

AGED; ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BREAST CANCER; BRONCHOSCOPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; LUNG CANCER; MALE; MAMMOGRAPHY; MELANOMA; NUTRITION; NUTRITIONAL ASSESSMENT; PROSTATE CANCER; VITAMIN SUPPLEMENTATION;

EID: 38348998845     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Murray, GI, Taylor, MC, McFadyen MCE, et al: Tumor-specific expression of cytochrome P450 CYP1B1. Canc Res, 1997; 57(14): 3026-3031.
2. McFadyen MC, Breeman S, Payne S, et al: Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J Histochem Cytochem, 1999; 47: 1457-1464.
3. Gibson P, Gill JH, Khan PA, et al: Cytchrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: Implications for drug development. Mol Canc Therap, 2003; 2(6): 527-534.
4. McFadyen, MCE, Melvin, WT, Murray GI: Cytochrome P450 CYP1B1 activity in renal cell Carcinoma. Brit J Canc, 2004; 91(5): 966-971.
5. Maecker B, von Bergwelt-Baildon MS, Anderson KS, et al: Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients. Clin Exper Immunol, 2005; 141(3): 558-562.
6. Tokizane T, Shiina H, Igawa M, et al: Cytchrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Canc Res, 2005; 11(16): 5793-5801.
7. Oyama T, Morita M, Isse T, et al: Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer. Frontiers Biosci, 2005; 10: 1156-1161.
8. Downie D, McFadyen MCE, Rooney, PH, et al: Profiling cytochrome P450 expression in ovarian cancer: Identification of prognostic markers. Clin Canc Res, 2005; 11(20): 7369-7375.
9. Potter GA, Burke MD: Salvestrols- Natural Products with Tumour Selective Activity. J Orthomol Med, 2006; 21(1): 34-36.
10. Tan HL, Butler PC, Burke MD, et al: Salvestrols: A New Perspective in Nutritional Research. J Orthomol Med, 2007; 22(1): 39-47.
11. Chu OA, Chung Y, Pepper MA: Juice processing incorporating resin treatment. USPTO, Patent No 7,108,887, 2006.
12. Daniel O, Meier, MS, Schlatter J, et al: Selected phenolic compounds in cultivated plants: Ecologic functions, health implications, and modulation by pesticides. Environ Health Perspect, 1999; 107: 109-114.
13. Magee JB, Smith BJ, Rimando A: Resveratrol content of muscadine berries is affected by disease control spray program. Hortscience, 2002; 37(2): 358-361.
14. Dana-Farber Cancer Institute: Cytochrome P450 1B1 is a Universal Tumor Antigen Eliciting Cytotoxic T Cell Responses, 2007 http://www.dana-farber. org/res/technology/available.asp?case_number=641&keywords=&category_id= 3&category_name=Researc+Reagents.